GRCE$1.80-0.83%
Grace Therapeutics, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$37.76M
Float & O/S:
Inst Own:
DilutionScan read 37 of Grace Therapeutics, Inc.'s SEC filings and found 5 warrant series, 3 shelf registrations and 1 completed offering on file for GRCE. The latest dilution event on file is a registration statement on Aug 31, 2026. Analysis updated Oct 7, 2026.
